In renal-specific RCTs such as DAPA-CKD and CREDENCE, the mean value of albuminuria, calculated as the urinary albumin-to-creatinine ratio (UACR), was 923 mg/g and 1017 mg/g, respectively, in people with T2DM receiving SGLT2i therapy. The gene discussed is ALB; the disease is chronic kidney disease.